Journal Guide

Benefits to authors
We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our http://www.elsevier.com/wps/find/authorsview.authors/authorservicesauthor services.

Please see our http://www.elsevier.com/wps/find/journaldescription.cws_home/623385/authorinstructionsGuide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

This journal is devoted to all areas of transfusion medicine. These include the quality and security of blood products, therapy with blood components and plasma derivatives, transfusion-related questions in transplantation, stem cell manipulation, therapeutic and diagnostic problems of hemostasis, immunohematological investigations, and legal aspects of the production of blood products as well as hemotherapy. Both comprehensive reviews and primary publications that detail the newest work in transfusion medicine and hemotherapy promote the international exchange of knowledge within these disciplines. Consistent with this goal, continuing clinical education is also specifically addressed.

Transfusion and Apheresis Science brings comprehensive and up-to-date information to physicians and health care professionals involved in the rapidly changing fields of transfusion medicine, hemostasis and apheresis. The journal presents original articles relating to scientific and clinical studies in the areas of immunohematology, transfusion practice, bleeding and thrombotic disorders and both therapeutic and donor apheresis including hematopoietic stem cells. Topics covered include the collection and processing of blood, compatibility testing and guidelines for the use of blood products, as well as screening for and transmission of blood-borne diseases. All areas of apheresis - therapeutic and collection - are also addressed. We would like to specifically encourage allied health professionals in this area to submit manuscripts that relate to improved patient and donor care, technical aspects and educational issues. Transfusion and Apheresis Science features a "Theme" section which includes, in each issue, a group of papers designed to review a specific topic of current importance in transfusion and hemostasis for the discussion of topical issues specific to apheresis and focuses on the operators' viewpoint. Another section is "What's Happening" which provides informal reporting of activities in the field. In addition, brief case reports and Letters to the Editor, as well as reviews of meetings and events of general interest, and a listing of recent patents make the journal a complete source of information for practitioners of transfusion, hemostasis and apheresis science. Immediate dissemination of important information is ensured by the commitment of Transfusion and Apheresis Science to rapid publication of both symposia and submitted papers.

The aim of the Turkish Journal Hematology is to publish original research papers of highest scientific and clinical value on hematology. Additionally, educational material, reviews on basic developments, editorial short notes, case reports, original views and letters from specialists on hematology, and hematology medicine covering their experience and comments as well as social subjects are published.

Vox Sanguinis reports on important, novel developments in transfusion medicine. Original papers, reviews and international fora are published on all aspects of blood transfusion and tissue transplantation, comprising five main sections:1) Transfusion - Transmitted Disease and its Prevention:*Identification and epidemiology of infectious agents transmissible by blood;*Bacterial contamination of blood components;* Donor recruitment and selection methods;* Pathogen inactivation.2) Blood Component Collection and Production:*Blood collection methods and devices (including apheresis);*Plasma fractionation techniques and plasma derivatives;* Preparation of labile blood components;* Inventory management;*Hematopoietic progenitor cell collection and storage;* Collection and storage of tissues;* Quality management and good manufacturing practice;* Automation and information technology.3) Transfusion Medicine and New Therapies:*Transfusion thresholds and audits;* Haemovigilance;* Clinical trials regarding appropriate haemotherapy;** Non-infectious adverse affects of transfusion;* Therapeutic apheresis;* Support of transplant patients;* Gene therapy and immunotherapy.4) Immunohaematology and Immunogenetics:* Autoimmunity in haematology;* Alloimmunity of blood;* Pre-transfusion testing;* Immunodiagnostics;* Immunobiology;* Complement in immunohaematology;* Blood typing reagents;* Genetic markers of blood cells and serum proteins: polymorphisms and function;* Genetic markers and disease;* Parentage testing and forensic immunohaematology.5) Cellular Therapy:* Cell-based therapies;Stem cell sources;** Stem cell processing and storage;* Stem cell products;* Stem cell plasticity;* Regenerative medicine with cells;* Cellular immunotherapy;* Molecular therapy;* Gene therapy.

The focus of the journal 'magazine of european medical oncology – memo' is to offer a professional review on current research and development in the field of hematology and oncology relevant for daily practice. Therefore, memo includes editorials and comments, peer-reviewed original reports, short reviews, case reports and controversies, articles explaining the biology of neoplasia and congress reports including qualified comments. As a European journal memo aims at highlighting the local peculiarities of various regions and at being a forum for the presentation of ongoing clinical and basic research.memo is the Official Journal of the Central European Cooperative Oncology Group (CECOG) and The Austrian Society of Haematology and Oncology (OeGHO).